$ANIK Company News Amgen boosts biotech sector to close

New Post Public Reply Private Reply Replies (0) Message Board

Nov 9, 2013 at 9:04 PM

$ANIK Company News

Amgen boosts biotech sector to close up 5:23 p.m. March 11, 2011 - Wallace Witkowski
Human Genome rallies against biotech downturn 5:04 p.m. March 10, 2011 - Wallace Witkowski
Illumina dives, Anika rallies on earnings reports 10:53 a.m. Oct. 28, 2009 - Val Brickates Kennedy
Genzyme, Merck lead as drug stocks move higher 12:04 p.m. Aug. 21, 2009 - Val Brickates Kennedy
Thursday's biggest gaining and declining stocks 4:07 p.m. Aug. 20, 2009 - MarketWatch
Drug stocks gain; Anika zooms on drug approval 11:32 a.m. Aug. 20, 2009 - Val Brickates Kennedy
Wednesday's biggest stock gainers and decliners 4:27 p.m. July 25, 2007 - Gabriel Madway
Stocks in focus for Wednesday 6:37 p.m. July 24, 2007 - MarketWatch
Friday's biggest stock gainers and decliners 3:42 p.m. April 13, 2007 - Michael Baron
Stocks in focus Friday 6:14 p.m. April 12, 2007 - Katherine Hunt
Anika Therapeutics receives CE Mark approval for Elevess 4:30 p.m. April 12, 2007 - Katherine Hunt
Anika Therapeutics up 5.3% at $14.10 9:46 a.m. Dec. 21, 2006 - Tomi Kilgore
Anika Thera gets FDA approval for cosmetic tissue augment 8:52 a.m. Dec. 21, 2006 - Thomas Middleton
Tuesday's biggest stock gainers and decliners 5:29 p.m. Nov. 28, 2006 - Gabriel Madway
Anika receives FDA approvable letter for tissue product 12:41 p.m. Nov. 28, 2006 - Katherine Hunt
Anika shares up $1.14 at $12.66 12:34 p.m. Nov. 28, 2006 - Katherine Hunt
Anika sees commercialization of CTA product in mid-2007 12:33 p.m. Nov. 28, 2006 - Katherine Hunt
Anika gets FDA OK for cosmetic tissue augmentation product 12:32 p.m. Nov. 28, 2006 - Katherine Hunt
Anika Therapeutics target is $17 - Sidoti 12:00 p.m. Nov. 27, 2006 - Leslie Wines
Anika Therapeutics starts at buy - Sidoti 11:59 a.m. Nov. 27, 2006 - Leslie Wines

10-Q: ANIKA THERAPEUTICS INC 4:08 p.m. Nov. 5, 2013 - Edgar Online - (EDG = 10Q, 10K)
5 Biotechnology Bargains With Attractive Fundamentals 12:06 a.m. Nov. 1, 2013 - Seeking Alpha
Anika's CEO Discusses Q3 2013 Results - Earnings Call Transcript 3:01 p.m. Oct. 31, 2013 - Seeking Alpha
Zacks #1 Rank Additions for Wednesday - Tale of the Tape 8:30 a.m. Aug. 14, 2013 - Zacks.com
Supernus Files Patent Infringement Lawsuit - Analyst Blog 3:00 p.m. Aug. 9, 2013 - Zacks.com
MDCO Acquires ProFibrix - Analyst Blog 4:35 p.m. Aug. 8, 2013 - Zacks.com
Data on BioLineRx' BL-8040 - Analyst Blog 4:10 p.m. Aug. 8, 2013 - Zacks.com
Osiris Loss Wider-Than-Expected - Analyst Blog 10:50 a.m. Aug. 7, 2013 - Zacks.com
Narrower-than-Expected Loss at Pacira - Analyst Blog 10:15 a.m. Aug. 7, 2013 - Zacks.com
Wider-than-Expected Loss at Avanir - Analyst Blog 10:08 a.m. Aug. 7, 2013 - Zacks.com
Pacira's Exparel Disappoints - Analyst Blog 4:25 p.m. Aug. 6, 2013 - Zacks.com
10-Q: ANIKA THERAPEUTICS INC 4:22 p.m. Aug. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
Astellas, FibroGen Start Phase II Study - Analyst Blog 3:45 p.m. Aug. 6, 2013 - Zacks.com
Anika Soars on Strong Q2 Results - Analyst Blog 8:31 a.m. Aug. 5, 2013 - Zacks.com
Anika Therapeutics' CEO Discusses Q2 2013 Results - Earnings Call Transcript 3:49 p.m. Aug. 1, 2013 - Seeking Alpha
Anika Therapeutics Inc. (ANIK) Management Discusses Q2 2013 Results (Webcast) 8:03 a.m. Aug. 1, 2013 - Seeking Alpha
Anika Therapeutics Inc. (ANIK) Management Discusses Q2 2013 Results (Webcast) 8:03 a.m. Aug. 1, 2013 - Seeking Alpha
Loss Narrows at Dynavax in Q2 - Analyst Blog 11:00 a.m. July 31, 2013 - Zacks.com
Anika Therapeutics: Profitable, Cheap And Overlooked 3:27 p.m. June 21, 2013 - Seeking Alpha
DaVita and Myriad Join Forces - Analyst Blog 5:25 p.m. June 18, 2013 - Zacks.com

Presentations, Executive Appointments, and Quarterly Financial Reports - Research Report on Jazz Pharmaceuticals, Insulet, The Cooper Companies, Anika Therapeutics, and Sangamo Biosciences 8:00 a.m. Nov. 6, 2013 - PR Newswire
Anika Therapeutics Reports 20% Total Revenue Growth and Record Third-Quarter Earnings 3:05 p.m. Oct. 30, 2013 - BusinessWire
Anika Therapeutics Announces Date of Third-Quarter 2013 Financial Results Conference Call 7:30 a.m. Oct. 15, 2013 - BusinessWire
Anika Therapeutics Appoints Industry-Recognized R&D Executive John W. Sheets, Jr., Ph.D. as Chief Scientific Officer 2:10 p.m. Oct. 2, 2013 - BusinessWire
Anika Therapeutics to Present at the Rodman & Renshaw Annual Global Investment Conference on September 10 3:05 p.m. Aug. 16, 2013 - BusinessWire
Anika Therapeutics to Present at the Midwest IDEAS Conference on August 27 3:00 p.m. Aug. 13, 2013 - BusinessWire
Strong Sales, Diversified Portfolio, and R&D Progress Boost Growth - Research Report on Teva, Auxilium, Nektar, Anika, and Vical 7:00 a.m. Aug. 6, 2013 - PR Newswire
Anika Therapeutics Reports Record Second-Quarter Revenue and Earnings 3:05 p.m. July 31, 2013 - BusinessWire
Anika Therapeutics Announces Date of Second-Quarter 2013 Financial Results Conference Call 11:18 a.m. July 12, 2013 - BusinessWire
Anika Therapeutics Reports First-Quarter 2013 Financial Results 4:32 p.m. May 1, 2013 - BusinessWire
Anika Therapeutics Announces Date of First-Quarter 2013 Financial Results Conference Call 8:00 a.m. April 5, 2013 - BusinessWire
Anika Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference on March 19 1:24 p.m. March 13, 2013 - BusinessWire
The Prescription of Success: Improving Pipelines, Increasing Capabilities - Research Report on Globus, Akorn, Anika, Orthofix and Sangamo Biosciences 8:00 a.m. March 5, 2013 - PR Newswire
Ubika Research's Daily US Box Score: Top Junior Technology (NASDAQ: RNIN) Stock Gained 109% 10:26 a.m. March 1, 2013 - ACCESSWIRE-TNW
Ubika Research's Daily US Box Score: Top Junior Technology (NASDAQ: RNIN) Stock Gained 109% 10:26 a.m. March 1, 2013 - ACCESSWIRE-TNW
Anika Therapeutics Reports Fourth Quarter and Full Year 2012 Financial Results 4:54 p.m. Feb. 27, 2013 - BusinessWire
Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2012 Financial Results Conference Call 8:00 a.m. Feb. 14, 2013 - BusinessWire
Anika Therapeutics Names Sylvia Cheung as Chief Financial Officer 8:30 a.m. Jan. 22, 2013 - BusinessWire
Anika Therapeutics Announces Monovisc PMA News 5:01 p.m. Dec. 4, 2012 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amgen's Board Gains Restaurateur Gibbs Amid Strategic Shift

A Heavyweight Joiner Shakes Up Amgen's Ranks You can almost feel the ground shake when Amgen, a tech giant in biotech, ropes in a high-profile namesake from outside its usual league. David W. Gibbs, the former CEO of Yum! Brands, is now staking his claim at Amgen as a member of its Board of Directors. Effective immediately, Gibbs isn’t just a filler; he's diving...

AI's Rise: Worth Watching for M&A Strategy Insights

AI: The Hot Topic You Can't Ignore AI's rocking the boat like SEO did back in the day, folks. The Digital WOW is giving M&A Source® members a real scoop with their exclusive webinar, zeroing in on AI's potential seismic shifts in mergers and acquisitions. This should make any investor sit up and pay attention. AI's not just a tech buzzword anymore. It's like a strong cup...

Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD

Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...

Texas Instruments' $2B Notes Fuel Acquisition Ambitions

Pushing Forward with Big Dollars Texas Instruments is setting the stage with an ambitious move by pricing $2.0 billion in investment-grade notes, preparing to shake things up with an acquisition. It's not every day you see a player like TXN dipping into the bond market with such confidence, yet here we are. Four series of senior unsecured notes are slated for issuance on...

E-Filing: Why Ditching IRS Paper Forms Matters Now

Tax Filing Today: The Old vs. The New Listen up, tax-filing warriors. Tackling that IRS Form 941 deadline isn’t just another play in the small business game—it’s crunch time. November 2, 2026, isn’t waiting around for excuses. Luckily, Halfpricesoft.com just chucked you a lifeline with their updated ezPaycheck platform. Swap that mountain of mangled paper forms...

Custom Concrete: Crafting the Perfect Poolside Paradise

Concrete: The Unsung Hero of Your Pool's Success You know, everyone always raves about that sparkling pool, but let's be real—it's the concrete holding the whole gig together. James White from White's Pools in Loganville, GA, drops some knowledge in a recent HelloNation piece about the unsung hero of backyard oases: custom concrete. Yeah, it's not sexy, but when you're...

Bertram Capital Backs MCE's Expansive Growth Vision

A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...

Energy Fuels Secures Key Financing for Donald Project

Donald Project: A Step Closer to Reality Look, when those rare earths start moving, the entire market gets a whiff of promise. Energy Fuels' Donald Rare Earth and Mineral Sands Project in Australia is gearing up for real action with a fresh funding nod. Export Finance Australia and the National Reconstruction Fund Corporation have conditionally greenlit up to A$180...

Skechers Facing Class Action: Investors Urged to Act

Skechers Under Fire: Fraud Allegations Surface Alright, if you've been around the stock block a while, you know these stories can often read like a suspense novel. Plot twist: Skechers U.S.A., Inc. (formerly NYSE: SKX) is now facing some serious accusations. There's a class action lawsuit claiming that some shady dealings went down during the company's $9.4 billion...

Brennan Takes a Swing: Barrasso Endorsement in Hand

Brennan Shakes Up Wyoming Politics You don’t need a crystal ball to see the chess game unfolding in Wyoming's political landscape. Shannon Brennan's bid for the House seat in Teton County's District 23 got a heavy artillery boost today. She’s landed the endorsement of Senator John Barrasso, none other than the Senate Majority Whip and a formidable player in the Senate...